Boehringer’s choice to go down growth of a joint prospect will certainly have no impact on the partnership with Gubra, the Danish biotech firm’s chief executive officer Henrik Blou highlights.
发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/gubra-after-dropped-obesity-candidate-now-comes-the-dialog-with-boehringer-ingelheim-2/